Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neural tissue xenografting.

L C Larsson1, H Widner

  • 1Department of Physiological Sciences, Section for Neuronal Survival, Wallenberg Neuroscience Center, Lund University, Lund, Sweden. Lena.Larsson@mphy.lu.se

Scandinavian Journal of Immunology
|September 6, 2000
PubMed
Summary

Neural transplantation shows promise for brain disorders like Parkinson's disease. Xenografts, using pig neural tissue, face immune rejection challenges that new research aims to overcome for broader clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.

Nature medicine·2026
Same author

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

European journal of neurology·2016
Same author

Memantine and reduced time with dyskinesia in Parkinson's Disease.

Acta neurologica Scandinavica·2015
Same author

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.

Acta neurologica Scandinavica·2012
Same author

Neuron-specific enolase correlates with other prognostic markers after cardiac arrest.

Neurology·2011
Same author

Detecting population structure in a high gene-flow species, Atlantic herring (Clupea harengus): direct, simultaneous evaluation of neutral vs putatively selected loci.

Heredity·2010

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Neural transplantation is a potential therapy for focal brain disorders, with notable success in Parkinson's disease patients.
  • Allogeneic grafts face limitations including ethical concerns and reliance on fetal tissue.
  • Xenografting offers an alternative but requires overcoming immunological rejection.

Purpose of the Study:

  • To review experimental data on immune responses to porcine neural xenografts in the adult brain.
  • To understand the mechanisms of immune rejection in neural xenotransplantation.
  • To explore strategies for preventing graft rejection and improving clinical outcomes.

Main Methods:

  • Review of experimental studies on immune reactions to grafted porcine neural tissue.
  • Analysis of the roles of antibodies, complement, natural killer (NK) cells, and lymphocytes.
  • Evaluation of immunosuppressive drugs and donor tissue modification effects.

Main Results:

  • Early clinical trials of porcine xenografts showed no proven functional benefits, likely due to graft rejection.
  • Immune responses involving antibodies, complement, NK cells, and lymphocytes contribute to xenograft rejection.
  • Immunosuppression and tissue modification strategies are being investigated to mitigate rejection.

Conclusions:

  • Preventing immunological rejection is critical for the clinical success of neural xenotransplantation.
  • Further research into immune mechanisms and therapeutic interventions is necessary for advancing xenograft therapies.
  • Overcoming immune barriers could enable wider clinical use of xenografts for neurological disorders.

Related Experiment Videos